The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy

The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy

Cervical carcinoma is one of the most common cancers among women globally. Histone deacetylase inhibitors (HDACIs) constitute anticancer drugs that, by increasing the histone acetylation level in various cell types, induce differentiation, cell cycle arrest, and apoptosis. The aim of the current rev...

Full description

Bibliographic Details
Main Authors: Iason Psilopatis, Nikolaos Garmpis, Anna Garmpi, Kleio Vrettou, Panagiotis Sarantis, Evangelos Koustas, Efstathios A. Antoniou, Dimitrios Dimitroulis, Gregory Kouraklis, Michail V. Karamouzis, Georgios Marinos, Konstantinos Kontzoglou, Afroditi Nonni, Konstantinos Nikolettos, Florian N. Fleckenstein, Christina Zoumpouli, Christos Damaskos
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Cancers
Subjects:
histone
deacetylase
inhibitor
cervical
cancer
therapy
Online Access:https://www.mdpi.com/2072-6694/15/8/2222

Internet

https://www.mdpi.com/2072-6694/15/8/2222

Similar Items